Muzurovic Emir,Macesic Marija V,Kavaric Sreten (2024) Liver Fibrosis and Atherosclerosis, a Consequence of Metabolic Dysfunction-Do They Share a Similar Pathophysiological Background?, ANGIOLOGY, vol. , br. , str. - (Editorial Material; Early Access) 

Bica Ioana-Cristina,Stoica Roxana Adriana,Salmen Teodor,Janez Andrej,Volcansek Spela,Popovic Djordje S,Muzurovic Emir,Rizzo Manfredi,Stoian Anca Pantea (2023) The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials, MEDICINA-LITHUANIA, vol. 59, br. 6, str. - (Review) 

Janez Andrej,Muzurovic Emir,Stoian Anca Pantea,Haluzik Martin,Guja Cristian,Czupryniak Leszek,Duvnjak Lea,Lalic Nebojsa M,Tankova Tsvetalina,Bogdanski Pawel,Papanas Nikolaos,Nunes Jose Silva,Kempler Peter,Fras Zlatko,Rizzo Manfredi (2022) Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group, INTERNATIONAL JOURNAL OF CARDIOLOGY, vol. 365, br. , str. 8-18 (Article) 

Muzurovic Emir,Zibar-Tomsic Karin,Vujosevic Snezana,Petakov Milan S (2022) Parathyroid hormone and calcitonin response during the calcium infusion test in patients with primary hyperparathyroidism, HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, vol. 21, br. 2, str. 261-270 (Article) 

Muzurovic Emir,Medenica Sanja,Kalezic Milovan,Pavlovic Sinisa U (2021) Primary hyperparathyroidism associated with acquired long QT interval and ventricular tachycardia, ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, vol. , br. , str. 1-6 (Article) 

Muzurovic Emir,Smolovic Brigita D,Vujosevic Snezana,Petakov Milan S (2021) Editorial on Prevalence, Diagnosis and Treatment with 3 Different Statins of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?, CURRENT VASCULAR PHARMACOLOGY, vol. 19, br. 5, str. 582-584 (Editorial Material)